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Abstract 
In addition to the Ca 2+ portion freely dissociated in the cytosol, another Ca 2+ pool is associated with plasma membranes 
and intracellular organelle membranes. This Ca 2+ portion is of importance for regulation of, among other things, the cell 
cycle, actin-mediated processes, and cell morphology. In the literature, dihydropyridines have been reported to influence this 
membrane-associated pool of Ca 2+ under certain conditions. The aim of this investigation was to study possible modulations 
of plasma membrane-associated Ca 2+ upon treatment with nifedipine in vitro in a Ca 2+-transporting cell, the dentin-forming 
odontoblast. The membrane-associated portion of Ca 2+ in dissected entinogenically active rat incisor odontoblasts was 
monitored by fluorescence spectrophotometry using chlortetracycline as a probe. In addition, images of chlortetracycline- 
Ca 2+ binding were obtained by fluorescence microscopy. It was found that membrane-associated Ca 2+ decreased by the 
dihydropyridine ifedipine, whereas this Ca 2+ pool was unaffected by the cellular polarization state, which was in contrast to 
cytosolic free Ca 2+ as measured by fura-2. The results show that the odontoblast plasma membrane-associated Ca2+-pool 
can be modulated by nifedipine, thus being dependent on the conformational state of the L-type Ca 2+ channels. © 1998 
Elsevier Science B.V. All rights reserved. 
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1. Introduction 
Odontoblasts play a central role during the forma- 
tion of dentin in that they synthesize the collagen 
and non-collagenous macromolecules of  the dentin 
organic matrix [1,2]. In addition, the odontoblasts 
are instrumental in mineral formation [3]. Earlier 
Abbreviations: [Ca2+]i, intracellular calcium activity; CTC, 
ehlortetracycline hydrochloride; DMSO, dimethylsulfoxide; 
EGTA, ethylene glycol-O,O'-bis(2-aminoethyl)-N,N,N;N'-tetra- 
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evidence shows that a transcellular oute for Ca 2+ 
transport is of  a central importance during active 
dentinogenesis [3-5]. For  this ion transport, a set of 
specialized mechanisms exist in odontoblasts, which 
by a concerted action gates Ca 2+ into the proximal 
end of the cells and extrude the ions at their distal 
end, close to the site of mineral formation. As in 
osteoblasts, a cell type in many respects closely re- 
lated to odontoblasts, the presence of  voltage-gated, 
dihydropyridine-sensitive Ca 2+ uptake channels has 
been described in odontoblasts [6,7]. Inhibition of 
such channels in vivo has been shown to suppress 
the uptake of  Ca 2+ ions into the dentin mineral 
phase during dentinogenesis [8]. In vitro, L-type 
Ca 2+ channels in odontoblasts can be manipulated 
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by inhibitory dihydropyridines, uch as nifedipine 
[6,7]. 
Cellular Ca 2+ is either freely dissociated in the 
cytosol or bound to Ca2+-complexing a ents such 
as, among other things, anionic counter ions, pro- 
teins, or membranes. Membrane-associated Ca 2÷ is 
believed to constitute an easily available pool of 
Ca 2+ for a variety of cellular functions. In different 
cell types, the cell cycle, actin-mediated processes, 
and cell morphology have been reported to be parti- 
ally dependent on membrane-associated Ca 2+ [9-13]. 
During pathological conditions, such as ischemia, 
anti-tubulin drug treatment, or hypertension, mem- 
brane-associated Ca2÷ may be released [14-18]. 
Dihydropyridines affect Ca2+-channels of the L- 
type in plasma membranes [19,20], but have also 
been reported to, directly or indirectly, influence 
the membrane-associated pool of Ca 2÷ under certain 
conditions. In neutrophils, for example, calcium 
channel antagonists have been shown to inhibit mo- 
bilization of membrane-associated Ca 2+ [21]. 
In addition to fura-2 and other fluorochromes, 
chlortetracycline (CTC) has been used for detection 
of cellular Ca 2+ by means of both conventional fluo- 
rescence spectrophotometry and fluorescence imag- 
ing [22-28]. Upon binding to biological membranes, 
the Ca2+-CTC complex becomes fluorescent, hereby 
making it a convenient probe for membrane-associ- 
ated Ca 2÷ [29-31]. In addition, this probe can be 
used to detect sequestered intracellular Ca z÷ 
[22,30,32-36]. 
The aim of the present study was to discriminate 
between the membrane-associated an free pools of 
Ca 2÷, and to examine whether plasma membrane- 
associated Ca 2+, in addition to free Ca 2÷, could be 
modulated by nifedipine in dentinogenically active 
rat incisor odontoblasts, a highly polarized cell type 
involved in bulk transport of Ca 2÷ during biominer- 
alization. 
acid were purchased from Calbiochem (La Jolla, CA, 
USA). DMSO stock solutions of pluronic F-127 
(10%) and cyclopiazonic acid (3 mM) were prepared. 
Digitonin, Triton X-100 and nifedipine were ob- 
tained from Sigma (St. Louis, MO, USA). A stock 
solution of nifedipine (1 mM) in DMSO was pre- 
pared. Fura-2/AM and chlortetracycline hydrochlo- 
ride were acquired from Fluka (Buchs, Switzerland). 
A stock solution of fura-2/AM (5 mM) in DMSO 
was prepared. The nifedipine, CTC and fura-2 stocks 
were stored in light-safe boxes, and light exposure, 
except during fluorescence measurements, was 
avoided. DMSO was purchased from Merck (Darm- 
stadt, Germany). All other reagents were of the high- 
est purity available. 
2.1. CTC fluorescence spectroscopy 
For each measurement, odontoblasts from two 
rats were dissected out [37]. Cellular CTC loading 
was in essence accomplished as described by Jy and 
Haynes [34]. The cells obtained were preincubated at
6°C in a CTC-containing (10 gM), calcium- and 
magnesium-flee Ringer medium for 30 min, after 
which an additional incubation was performed for 
20 min in a thermostated cuvette at 37°C. When 
nifedipine was present, it was used at a 5 gM con- 
centration. Every single addition (30 gl) to the cu- 
vette corresponded to 1% of the total sample volume 
(3 ml). Cellular calcium influx was initiated by the 
addition of CaCI2 at a 2 mM final concentration. 
CTC measurements were performed with a Perkin- 
Elmer LS 50B luminescence spectrometer at 390 nm 
excitation and 515 nm emission wavelengths in a 
quartz cuvette at 37°C. The arbitrary fluorescence 
units were set to zero at the onset of measurement. 
The integrity of the cells was controlled at the end of 
each measurement by the addition of digitonin to the 
cuvettes to check for alterations in fluorescence. 
2. Materials and methods 
Sprague-Dawley rats (body weight 200-400 g; 
B&K Universal, Sollentuna, Sweden) were used. 
The rats were conditioned in the animal facility prior 
to the experiments and fed a conventional diet and 
water ad libitum. Pluronic F-127 and cyclopiazonic 
2.2. CTC fluorescence microscopy 
CTC incubations were performed essentially ac- 
cording to the method of Engelmann et al. [22]. Dis- 
sected odontoblasts [37] from two rats, i.e., eight in- 
cisors, were Ca  2+ depleted in a cyclopiazonic acid (30 
gM)- and EGTA (0.1 mM)-containing medium. 
After 1 h of incubation at 37°C, cells were collected 
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at 500×g for 10 min and washed four times in the 
buffer prior to the CTC incubation. The odonto- 
blasts were then incubated in a Ringer medium con- 
taining 100 gM CTC at 37°C for 30 min, and the 
cells were pelleted at 500xg for 10 min and washed 
once. The cells were resuspended in 50-100 gl of 
buffer and were placed on a glass slide with a glass 
cover. Fluorescence was recorded at room temper- 
ature in a Nikon Diaphot fluorescence microscope 
equipped with a BV-2A fluorescence filter block. 
Results are presented as means + S.E.M. Statistical 
analyses were performed using a computerized paired 
Student's t-test (StatView 4.01). The experiments 
were reviewed and approved by the Animal Research 
Ethics Committee at G6teborg University. 
3. Results 
3.1. CTC fluorescence spectroscopy 
2.3. Fura-2 fluorescence spectroscopy 
For each measurement, odontoblasts from incisors 
of 4-5 rats were dissected out [37]. Fura-2/AM load- 
ing was performed essentially as described by Tho- 
mas and Delaville [38]. Briefly, freshly dissected cells 
were incubated for 30 min in a fura-2/AM (5 gM)- 
and Pluronic F-127 (0.025%)-containing Ringer me- 
dium at 37°C with slow stirring. The cells were spun 
down at 500×g for 10 min and washed twice. The 
cell pellet was then suspended in the Ringer medium, 
being either calcium-containing or not. Nifedipine, if 
present, was used at a 5 gM concentration. In some 
measurements, cellular calcium influx was initiated 
by the addition of CaC12 at a 2 mM final concentra- 
tion. At the end of each run, fluorometry calibrations 
were made with additions of Triton X-100 followed 
by EGTA. Every single addition of drugs or chem- 
icals to the measurement cell corresponded to 1% (30 
gl) of the total sample volume (3 ml). Intracellular 
calcium measurements were performed in a double- 
beam luminescence spectrometer at 340 and 380 nm 
excitation and 510 nm emission wavelengths, in a 
quartz cuvette at 37°C with slow magnetic stirring. 
[Ca2+]i was calculated using Kd = 220 for fura-2. 
2.4. Plasma membrane depolarization 
In one series of experiments, odontoblast plasma 
membranes were depolarized uring the measure- 
ments. This was achieved by replacing the Ringer 
medium with a high K+-containing medium (120 
mM). In the CTC measurements, the cells were 
spun down as above after the CTC incubation and 
afterwards resuspended in the high-K + medium. In 
the fura-2 measurements, he high-K + medium was 
added after the last pellet wash. 
When treated with nifedipine in a physiological, 
low-K + medium, the CTC fluorescence was found 
to decrease, reaching its lowest level after 600 s 
(Fig. 1). This decrease differed significantly from 
the baseline level (P < 0.001, n = 6). 
The CTC fluorescence was not altered when odon- 
toblasts in a Ca2+-containing medium were depolar- 
ized by a 120 mM K+-containing medium. The ad- 
dition of nifedipine under these conditions did not 
result in any statistically significant difference in flu- 
orescence ither (Fig. 1). 
In the fluorescence microscope, the circumference 
of CTC-loaded odontoblasts was clearly delineated. 
The periphery of the nucleus as well as non-discern- 
ible intracellular structures were also vaguely labeled 
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Fig. 1. Dependence of nifedipine and plasma membrane d po- 
larization on CTC fluorescence. The nifedipine ffects differed 
significantly from the baseline value (P < 0.001, n=7). When de- 
polarized in a K+-containing medium (120 raM), the odonto- 
blast CTC fluorescence in a Ca2+-containing medium did not 
change. A further addition of nifedipine did not yield any stat- 
istically significant effect on the fluorescence (n = 7). 
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Fig. 2. (A) Dependence of nifedipine on CTC fluorescence. In the fluorescence microscope, the circumference of CTC-treated odonto- 
blasts appeared clearly. The periphery of the nucleus and non-discernible intracellular structures were also vaguely labeled. (B) After 
treatment with nifedipine, the cell surface CTC fluorescence disappeared, in addition to the intracellular labeling. Bars--50 p.m. 
(Fig. 2A). After treatment with nifedipine, the plas- 
ma membrane CTC fluorescence disappeared as did 
the other intracellular labeling (Fig. 2B). 
3.2. Fura-2 fluorescence spectroscopy 
When depolarized in a K+-containing medium 
(120 mM), odontoblasts exhibited a rise in [Ca2+]i 
upon addition of extracellular Ca 2+, reaching a max- 
imum value after 300 s (Fig. 3). In contrast, this 
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Fig. 3. Dependence of nifedipine and plasma membrane depo- 
larization on fura-2 fluorescence. When depolarized in a K +- 
containing medium (120 mM), the cells exhibited an increase in 
[Ca2+]i upon addition of extracellular Ca 2+, reaching a maxi- 
mum value after 300 s. Under the same conditions, nifedipine- 
treated cells differed significantly from the untreated cells after 
300 s (P < 0.05, n = 6). 
effect was not obtained in the presence of nifedipine, 
and this difference was significant after 300 s 
(P < 0.05, n = 6). 
4. Discussion 
Ca 2+ binding, influx and release were measured 
with fluorescence spectroscopy using CTC and 
fura-2 as Ca 2+ probes [29-31,38]. CTC has been 
used for detection of cellular Ca 2+ by means of 
both conventional fluorescence spectrophotometry, 
and fluorescence imaging. In contrast o CTC, fura- 
2 reflects cytosolic free Ca 2+ [38], whereas CTC 
measures membrane-associated Ca 2+. Due to its 
low dissociation constant for Ca 2+, fura-2 is conven- 
ient for the detection of Ca 2+ within the nanomolar 
range. The apparent Kd of CTC for Ca 2+ in an aque- 
ous environment is about 400 ~tM [39,40] or even as 
high as about 3 mM [25]. Due to this high Kd for 
Ca 2+, the CTC fluorescence signal originates from 
pools in cells with mM concentrations of Ca 2+. 
CTC has, among other things, been used to evaluate 
the acrosome reaction of sperm [27,28], as well as 
intravesicular Ca 2+ in a variety of cells [22- 
25,29,33,39,40]. The probe has, however, so far 
never been used to detect cellular Ca 2+ in a cell 
type involved in biomineralization. Other types of 
tetracyclines, though, have been shown to interact 
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with osteoblasts. Chemically modified tetracycline 
binds along plasma membranes of osteoblasts [26]. 
In an aqueous milieu, CTC binds to Ca 2+ in pro- 
portion to the [Ca2+]i [33], and then preferentially 
associates with membranes [29,34,41~4]. Alterations 
in fluorescence represent changes in the pool of 
membrane-associated Ca 2÷ [43], where fluorescence 
intensity increases about 20-fold upon Ca2+-binding 
[25]. 
When incubating odontoblasts with cyclopiazonic 
acid, a Ca2+-ATPase inhibitor, the endoplasmic re- 
ticulum Ca2+-ATPase is impaired, resulting in a 
Ca 2÷ release from the endoplasmic reticulum and 
an increase in [Ca2+]i [7]. A simultaneous treatment 
with EGTA withdraws Ca 2+ that can bind to CTC. 
This procedure was performed prior to treatment 
with CTC and extracellular Ca 2÷ in order to extinct 
intracellular fluorescence. Thus, the fluorescence ob- 
served primarily emanated from CTC-Ca 2+ com- 
plexes bound to the exterior plasma membrane. 
The cell cycle, actin-mediated processes, and cell 
morphology have been shown to be, at least in 
part, dependent on membrane-associated Ca 2+ [9- 
13]. Further, during ischemia, anti-tubulin drug 
treatment or hypertension, membrane-associated 
Ca 2÷ may be released [14-18]. This membrane-asso- 
ciated pool of Ca 2+ has been reported to be sensitive 
for dihydropyridines; in neutrophils, for example, 
calcium channel antagonists inhibit mobilization of 
this Ca z+ pool [21]. Upon binding of nifedipine, the 
amount of membrane-associated Ca 2+ in odonto- 
blasts decreased. If the plasma membranes were de- 
polarized, the CTC fluorescence was not influenced 
by the presence of nifedipine. (Fig. 1). In the depo- 
larized, open state, the Ca2+-channel Ca 2+ affinity 
was not affected by the inhibitory nifedipine. The 
changes in amount of membrane-associated Ca 2+ 
after treatment with nifedipine may be interpreted 
as alterations in the membrane affinity for Ca 2+. 
When in a closed conformational state, the L-type 
Ca2+-channel affinity for Ca 2+ might be changed. 
The possibility of nifedipine to, in addition, influence 
membrane-associated Ca 2+ not in conjunction with 
Ca2+-channels cannot be ruled out, however. Nifedi- 
pine might, for example, influence the lipophilic 
properties of the CTC Ca z-- complexes, or in some 
other way quench the CTC-Ca 2+ complex fluores- 
cence at the dose (5 ktM) used. It might also be pos- 
sible that part of the fluorescence decrease is due to 
nifedipine making less Ca 2+ available to intracellular, 
and fluorescent, Ca 2+ stores. 
In the fluorescence microscope, the odontoblast 
plasma membrane-associated CTC fluorescence ap- 
peared clearly (Fig. 2A). After treatment with nifedi- 
pine the cell surface CTC fluorescence disappeared in
addition to the intracellular labeling (Fig. 2B). This 
result shows that it is possible to deplete odonto- 
blasts of Ca 2÷ with cyclopiazonic acid and EGTA, 
and that the CTC fluorescence observed was a nife- 
dipine-sensitive binding of Ca 2+ to the plasma mem- 
brane, in concordance with the fluorescence spectro- 
photometry measurements. 
In fura-2 fluorescence measurements, depolariza- 
tion increased the [Ca2+]i n a Ca2+-containing me- 
dium, demonstrating the opening of voltage-gated 
Ca 2+ channels (Fig. 3). This is in accordance with 
our earlier findings [8], where nifedipine xhibited a 
pronounced effect on Ca 2+ uptake into dentin in 
vivo. The functional importance of the L-type Ca 2+ 
channels during osteogenesis and dentinogenesis is 
shown by the fact that their specific inhibition in 
vivo strongly suppresses the uptake of Ca 2+ ions 
into both dentin and bone [8,45]. The lack of a total 
inhibition of inward Ca 2+ fluxes, observed upon ni- 
fedipine treatment, is most probably explained by the 
presence of other Ca 2÷ uptake pathways as well [7]. 
Nifedipine decreased the cell surface affinity prop- 
erties for Ca 2+, in addition to inhibition of cellular 
Ca 2+ uptake. In the depolarized open state, the Ca 2+ 
channel Ca 2+ affinity was not affected by the inhib- 
itory nifedipine. Ca 2+ uptake, with an increase in 
[Ca2+]i, however, was stimulated by depolarization. 
In addition to further evidence for the presence of 
voltage-gated, ihydropyridine-sensitive Ca 2÷ chan- 
nels in rat incisor odontoblast plasma membranes, 
this in vitro study demonstrated a modulation by 
nifedipine of the plasma membrane-associated pool 
of Ca 2+. The membrane affinity for Ca 2+ might in 
part be dependent on the conformational state of, 
presumably, L-type Ca 2+ channels. As these channels 
are instrumental for hard tissue formation [8,45], a 
dihydropyridine-dependent membrane affinity for 
Ca 2+ might be a factor of significance for biological 
mineralization. 
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